-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2024.
- Dianthus Therapeutics, Inc. /DE/ Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $218 M.
- Dianthus Therapeutics, Inc. /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $134 M, a 38.2% increase from 2022.
- Dianthus Therapeutics, Inc. /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $96.7 M, a 548% increase from 2021.
- Dianthus Therapeutics, Inc. /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2021 was $14.9 M, a 78% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)